X0508 4 2025-01-02 false 0001770121 Sana Biotechnology, Inc. SANA 0001568605 Wyrick Susan D. C/O SANA BIOTECHNOLOGY, INC. 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 false true false false See Remarks false Common Stock 2025-01-02 4 M false 5000.00 0.00 A 155512.00 D Common Stock 2025-01-02 4 F false 1566.00 1.65 D 153946.00 D Restricted Stock Units 2025-01-02 4 M false 5000.00 0.00 D Common Stock 5000.00 7500.00 D Includes 3,000 shares acquired on November 15, 2024 pursuant to Sana Biotechnology, Inc.'s ("Sana") 2021 Employee Stock Purchase Plan. Each restricted stock unit represents a contingent right to receive one share of Sana common stock. The award vested as to 40% of the restricted stock units on January 2, 2025 and the remaining 60% of the restricted stock units will vest on January 2, 2026, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date. Acting Chief Financial Officer and Principal Accounting Officer /s/ Julie Shah, Attorney-in-Fact for Susan D. Wyrick 2025-01-03